Description

This issue of Vital Signs, released on June 5, 2006, provides a strategic overview of the potential impact of Medicare cuts on the oxygen therapy market. Additionally, an emerging company profile is provided on Inogen, a company that is redefining oxygen therapy. Reimbursement and regulatory news from the FDA and CMS are also provided for the week of May 17 - May 25, 2006.